Hypothalamic, pituitary, and ovarian function assessment in a patient with anorexia nervosa.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000311:Adrenal Glands / Q000503:physiopathology; D000328:Adult; D000568:Amenorrhea / Q000150:complications; D000856:Anorexia Nervosa / Q000150:complications / Q000503:physiopathology*; D004717:Endometrium / Q000503:physiopathology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology*; D007986:Luteinizing Hormone / Q000097:blood; D010053:Ovary / Q000503:physiopathology*; D010902:Pituitary Gland / Q000503:physiopathology*; D011276:Pregnanediol / Q000652:urine; D011374:Progesterone / Q000097:blood; D011863:Radioimmunoassay; D013961:Thyroid Gland / Q000503:physiopathology; D013972:Thyrotropin / Q000097:blood
D015065:17-Hydroxycorticosteroids; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D011276:Pregnanediol